126 related articles for article (PubMed ID: 38488021)
1. [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152
Teng Z; Xu S; Lei Q
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38488021
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] MicroRNA‑329‑3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
Li W; Liang J; Zhang Z; Lou H; Zhao L; Xu Y; Ou R
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38695244
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.
Li S; Wang H; Ma R; Wang L
Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940344
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK.
Liang X; Ju J
Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38904204
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] MicroRNA‑362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
Shi C; Zhang Z
Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38334137
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
Yan H; Qiu C; Sun W; Gu M; Xiao F; Zou J; Zhang L
Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38963052
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004468
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38099365
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38391013
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] MicroRNA‑338‑3p functions as tumor suppressor in breast cancer by targeting SOX4.
Jin Y; Zhao M; Xie Q; Zhang H; Wang Q; Ma Q
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38186300
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] MicroRNA‑140 represses glioma growth and metastasis by directly targeting ADAM9.
Liu X; Wang S; Yuan A; Yuan X; Liu B
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456498
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] IQGAP1‑siRNA inhibits proliferation and metastasis of U251 and U373 glioma cell lines.
Diao B; Liu Y; Zhang Y; Yu J; Xie J; Xu GZ
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37732553
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] MicroRNA‑939‑5p directly targets IGF‑1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
Zhao X; Li J; Yu D
Int J Mol Med; 2022 Oct; 50(4):. PubMed ID: 36004489
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
Xu Y; Hu J; Zhang C; Liu Y
Mol Med Rep; 2024 Mar; 29(3):. PubMed ID: 38275108
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] Effect of RhoC on the epithelial‑mesenchymal transition process induced by TGF‑β1 in lung adenocarcinoma cells.
Lu X; Guo H; Chen X; Xiao J; Zou Y; Wang W; Chen Q
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240098
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] MicroRNA‑383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.
Yan F; Tu Z; Duan L; Wang D; Lin F
Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37477138
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] Isoquercitrin inhibits bladder cancer progression
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131234
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4.
Hu JM; He LJ; Wang PB; Yu Y; Ye YP; Liang L
Int J Mol Med; 2024 Mar; 53(3):. PubMed ID: 38299238
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642668
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.
Wang Q; Wang J; Niu S; Wang S; Liu Y; Wang X
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
